Chromosomal localization of the Hst oncogene and its coamplification with the int-2 oncogene in human melanoma
Adelaide J., Matter M.G., Marics I., Raybaund F., Planche J., Lapeyriere O.D. and Birnbaum D. (1988). Chromosomal localization of the Hst oncogene and its coamplification with the int-2 oncogene in human melanoma. Oncogene 2, 413-416.
High incidence of p53 alterations (mutation, deletion, overexpression) in head and neck primary tumors and metastases; absence of correlation with clinical outcome. Frequent protein overexpression in normal epithelium and in early non-invasive lesions
Ahomadegbe J.C., Fogel B.S., Le Bihan M.L., Douc-Rasy S., Duvillard P., Armand J.P. and Riou G. (1995). High incidence of p53 alterations (mutation, deletion, overexpression) in head and neck primary tumors and metastases; absence of correlation with clinical outcome. Frequent protein overexpression in normal epithelium and in early non-invasive lesions. Oncogene 10, 1217-1227.
The amplification unit of chromosome 11q13 in aggressive primary breast tumors entails the bcl-1, int-2, and hst loci
Ali I.U., Merlo G., Gallahan R. and Liderean R. (1989). The amplification unit of chromosome 11q13 in aggressive primary breast tumors entails the bcl-1, int-2, and hst loci. Oncogene 4, 89-92.
Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer
Allred D.C., Clark G.M., Elledge R., Fuqua S.A., Brown R.W., Chamness G.C., Osborne C.K. and McGuire W.L. (1993), Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer. J. Natl. Cancer Inst. 85, 200-206.
Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes
Almoquera C., Shibata D., Forrester K., Martin J., Arnheim N. and Perucho M. (1988). Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 53, 549-554.
